Home›Retrovir

Retrovir

7 interactions on record

Retrovir has 7 known drug interactions based on U.S. FDA drug labeling data. 5 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Atidarsagene Autotemcel, Elivaldogene Autotemcel, Lovotibeglogene Autotemcel. Patients taking Retrovir should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 7
Major: 5

Major (5)

Retrovir + Atidarsagene Autotemcel— Do not take anti-retroviral medications for at least one month prior to initiating stem cell mobilization. Anti-retrovir…
Retrovir + Elivaldogene Autotemcel— Anti-retrovirals must be discontinued at least one month prior to stem cell mobilization and continued through apheresis…
Retrovir + Lovotibeglogene Autotemcel— Anti-retroviral medications may interfere with manufacturing of LYFGENIA. Discontinue at least one month prior to mobili…
Retrovir + Marnetegragene Autotemcel— Do not take for one month prior to mobilization or expected duration for elimination, and until all apheresis cycles com…
Retrovir + Marnetegragene Autotemcel— Patients should not take anti-retroviral medications for at least one month prior to stem cell mobilization and until al…

Retrovir + Atidarsagene Autotemcel⚠️Major

Do not take anti-retroviral medications for at least one month prior to initiating stem cell mobilization. Anti-retroviral medications may interfere with the manufacturing of LENMELDY.

Retrovir + Elivaldogene Autotemcel⚠️Major

Anti-retrovirals must be discontinued at least one month prior to stem cell mobilization and continued through apheresis completion, as they may interfere with SKYSONA manufacture.

Retrovir + Lovotibeglogene Autotemcel⚠️Major

Anti-retroviral medications may interfere with manufacturing of LYFGENIA. Discontinue at least one month prior to mobilization and until all cycles of apheresis are completed. Some long-acting anti-retrovirals may require longer discontinuation.

Retrovir + Marnetegragene Autotemcel⚠️Major

Do not take for one month prior to mobilization or expected duration for elimination, and until all apheresis cycles completed. May interfere with manufacturing of apheresed cells.

Retrovir + Marnetegragene Autotemcel⚠️Major

Patients should not take anti-retroviral medications for at least one month prior to stem cell mobilization and until all apheresis cycles are completed. Anti-retrovirals may interfere with KRESLADI manufacturing.

Retrovir + Methadone Hydrochlorideℹ️Unknown

May result in decreased efficacy or increased toxicity of methadone.

Retrovir + Zidovudineℹ️Unknown

( 7.3 ) 7.1 Antiretroviral Agents Stavudine Concomitant use of zidovudine with stavudine should be avoided since an antagonistic relationship has been demonstrated in vitro. Nucleoside Analogues Affecting DNA Replication Some nucleoside analogues affecting DNA replication, such as ribavirin, antagonize the in vitro antiviral activity of RETROVIR against HIV-1; concomitant use of such drugs should be avoided.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.